Product
Supplier
Encyclopedia
Inquiry

EN

Home > Chemial Exhibition > Pharma Exhibition > CPhI Japan postponed until April 2021

CPhI Japan postponed until April 2021

Informa 2021-04-07

Over the course of the last few months, we have been in constant discussion with partners and key industry stakeholders to stay abreast of the challenges and complexities that each sector of the pharma industry is facing due to COVID-19.


This has included working closely with all partners and key industry stakeholders involved in CPhI Japan to determine if the show scheduled for September 2020 in Osaka would be both practical and beneficial to the market.


From a health and safety standpoint, we felt confident we could deliver a safe and secure event incorporating the highest hygiene standards.


However, CPhI Japan is an international event that attracts key industry players from around the globe. With international travel only returning gradually, Japan’s borders currently closed and each country at a different stage of recovery following the COVID-19 outbreak, it has become apparent that it would be difficult to guarantee the level of participation and high-quality experience expected of CPhI Japan.

Event Postponement

We have agreed with our partners and key industry stakeholders to postpone CPhI Japan until 14-16 April 2021 and focus on other ways in which we can support the pharma industry in the remainder of 2020, with a commitment that CPhI Japan will return stronger than ever next year.


By acting now, we hope to provide you with enough time to adjust your travel plans, avoid unnecessary expense and adapt to new opportunities the CPhI group has developed to fill the gap left by our in-person events in 2020.

 

Event Alternatives: Digital Networking & Learning

Whilst we will not be able to hold our in-person event in Osaka this year, we are looking into alternative digital opportunities that the CPhI Japan community can take advantage of.


We recognise that networking and knowledge sharing on a global scale is of utmost importance for Japanese manufacturers to deliver drugs to the market in a consistent way, so we endeavour to share the online opportunities that will allow this with you as soon as possible.


We sincerely apologise for any inconvenience caused and appreciate your understanding and cooperation during these unprecedented times. 

Share to:
Disclaimer: ECHEMI reserves the right of final explanation and revision for all the information.
Previous:

CPhI Discover

Trade Alert

Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)

Scan the QR Code to Share

Suggestions
Email:
Message:
Send Message